Bioreactors Market to grow at ~7% CAGR with rising production of monoclonal antibodies by 2030
The global bioreactors market is expected to grow at a CAGR of ~7%, driven by increasing demand for biopharmaceuticals like monoclonal antibodies, gene therapies, and advanced vaccines. The adoption of single-use bioreactors (SUBs) is accelerating due to their advantages in reducing downtime & contamination risks and enhancing manufacturing flexibility. CDMOs are heavily investing in SUBs to […]
Continue Reading